日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer

免疫疗法IL-6R和靶向MCT-1/IL-6/CXCL7/PD-L1通路可预防三阴性乳腺癌的复发和转移

Haq, Aushia Tanzih Al; Yang, Pao-Pao; Jin, Christopher; Shih, Jou-Ho; Chen, Li-Mei; Tseng, Hong-Yu; Chen, Yen-An; Weng, Yueh-Shan; Wang, Lu-Hai; Snyder, Michael P; Hsu, Hsin-Ling

Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.

体细胞 A-to-I RNA 编辑的 RHOA 异构体 2 特异性 R176G 突变促进肺腺癌的肿瘤进展

Chen Kuan-Ju, Huang Jing-Hsiang, Shih Jou-Ho, Gu De-Leung, Lee Szu-Shuo, Shen Roger, Hsu Yu-Hsuan, Kung Ying-Chih, Wu Cheng-Yen, Ho Chun-Ming, Jen Hsin-Wei, Lee Hsin-Yi, Lang Yaw-Dong, Hsiao Chen-Hao, Jou Yuh-Shan

Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.

对非编码 RNA 的综合分析揭示了增强肺腺癌肿瘤恶性程度的潜在机制

Shih Jou-Ho, Chen Hsin-Yi, Lin Shin-Chih, Yeh Yi-Chen, Shen Roger, Lang Yaw-Dong, Wu Dung-Chi, Chen Chien-Yu, Chen Ruey-Hwa, Chou Teh-Ying, Jou Yuh-Shan